Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03539094 · ClinicalTrials.gov registry record · NA
Intermittent Fasting in Multiple Sclerosis
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT03539094 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 61 participants.
The verdict
NCT03539094, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
This is a randomized controlled trial that will test the effects of intermittent fasting (IF) in subjects with relapsing-remitting MS (RRMS). The goal of this clinical trial is to acquire objective evidence regarding whether an IF diet has beneficial effects in MS patients.Two dietary regimens, IF and western diet, will be compared in a randomized, controlled, single-blinded 12 week trial in RRMS patients. This is a single-center study.
Interventions
- OTHER Intermittent fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2022-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03539094
The ClinicalTrials.gov registry entry for NCT03539094 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intermittent fasting is the first listed.
NCT03539094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03539094 about?
NCT03539094 is a clinical study titled "Intermittent Fasting in Multiple Sclerosis". This is a randomized controlled trial that will test the effects of intermittent fasting (IF) in subjects with relapsing-remitting MS (RRMS). The goal of this clinical trial is to acquire objective evidence regarding whether an IF diet has beneficial effects in MS patients.Two dietary regimens, IF a...
What is the current status of trial NCT03539094?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2018-01-01. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT03539094?
The interventions under investigation include: Intermittent fasting (OTHER).
Who is sponsoring clinical trial NCT03539094?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.